Compare BMRN & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | COKE |
|---|---|---|
| Founded | 1996 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.0B |
| IPO Year | 1999 | N/A |
| Metric | BMRN | COKE |
|---|---|---|
| Price | $53.40 | $167.97 |
| Analyst Decision | Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $88.42 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 507.2K |
| Earning Date | 10-27-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.59% |
| EPS Growth | ★ 59.53 | 22.14 |
| EPS | 2.68 | ★ 7.03 |
| Revenue | $3,094,001,000.00 | ★ $7,070,308,000.00 |
| Revenue This Year | $13.39 | N/A |
| Revenue Next Year | $7.57 | N/A |
| P/E Ratio | ★ $19.92 | $23.91 |
| Revenue Growth | ★ 12.39 | 4.22 |
| 52 Week Low | $50.76 | $105.21 |
| 52 Week High | $73.51 | $168.21 |
| Indicator | BMRN | COKE |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 81.43 |
| Support Level | $53.03 | $160.59 |
| Resistance Level | $54.66 | $165.06 |
| Average True Range (ATR) | 1.45 | 3.33 |
| MACD | -0.11 | -0.54 |
| Stochastic Oscillator | 31.61 | 97.79 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.